NYSE:TMOLife Sciences
Why Thermo Fisher Scientific (TMO) Is Up 6.7% After Q2 Beat, Buyback Completion, And InstaFlux Launch
Earlier this week, Thermo Fisher Scientific reported second-quarter 2026 results showing sales of US$11.99 billion and net income of US$1.74 billion, alongside the completion of a US$4.00 billion share repurchase program and the global launch of its InstaFlux media-on-demand workflow for food microbiology labs.
These updates highlight how Thermo Fisher is pairing earnings growth with efficiency-focused innovations like InstaFlux and new pharma services work such as the Kapiglucagon contract...